<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04093947</url>
  </required_header>
  <id_info>
    <org_study_id>prot2019</org_study_id>
    <nct_id>NCT04093947</nct_id>
  </id_info>
  <brief_title>Characteristics of Subjects With Overweight or Obesity at the Onset of Hypertension</brief_title>
  <official_title>Characteristics of Subjects With Overweight or Obesity at the Onset of Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the characteristics of subjects with hypertension at onset
      among a cohort of apparently healthy subjects, with overweight or obesity (BMI â‰¥ 25 Kg / m2),
      and free of any drug treatment at the baseline. The evaluation includes anthropometric
      (weight, height, BMI, waist circumference), haematochemical (hormones, metabolic and routine)
      parameters and the screening for hypertension with ABPM. The diagnosis of hypertension is
      made in accordance with the 2017 guidelines of the American College of Cardiology / American
      Heart Association ACC / AHA.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin</measure>
    <time_frame>At baseline</time_frame>
    <description>Insulin (mIU/L) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Potassium</measure>
    <time_frame>At baseline</time_frame>
    <description>Potassium (mmol/L) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sodium</measure>
    <time_frame>At baseline</time_frame>
    <description>Sodium (mEq/L) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>eGFR (estimated glomerular filtration rate)</measure>
    <time_frame>At baseline</time_frame>
    <description>eGFR (ml/min/1.73 mq)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Creatinin</measure>
    <time_frame>At baseline</time_frame>
    <description>Creatinin (mg/dl) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Uric acid</measure>
    <time_frame>At baseline</time_frame>
    <description>Uric acid (mg/dL) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>At baseline</time_frame>
    <description>Total cholesterol (mg/dL) concentrations in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thyroid hormones (FT3, FT4)</measure>
    <time_frame>At baseline</time_frame>
    <description>FT3 (pg/mL), FT4 (pg/mL) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>At baseline</time_frame>
    <description>HDL cholesterol (mg/dL) concentrations in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>At baseline</time_frame>
    <description>LDL cholesterol (mg/dL) concentrations in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>At baseline</time_frame>
    <description>Triglycerides (mg/dL) concentrations in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TSH</measure>
    <time_frame>At baseline</time_frame>
    <description>TSH (mU/L) concentration in serum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>At baseline</time_frame>
    <description>BMI (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>At baseline</time_frame>
    <description>Height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>At baseline</time_frame>
    <description>Weight in kilograms</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hypertension</condition>
  <condition>Obesity</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational study</intervention_name>
    <description>Observational and prospective study</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who came to the Outpatient Clinic of Nutrition at the National Institute of
        Gastroenterology &quot;S. de Bellis,&quot; Research Hospital, Castellana Grotte, Italy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight or obesity (BMI&gt; 25 Kg/m2)

        Exclusion Criteria:

          -  Any kind of drug

          -  Hypertension

          -  Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism,
             etc.),

          -  Chronic inflammatory diseases

          -  Renal failure

          -  Liver failure

          -  Angina pectoris

          -  Myocardial infarction and heart failure

          -  Genetic heart diseases

          -  Thrombocytopenias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institute of Gastroenterology IRCCS S. de Bellis</name>
      <address>
        <city>Castellana Grotte</city>
        <state>Bari</state>
        <zip>70013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 27, 2019</study_first_submitted>
  <study_first_submitted_qc>September 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2019</study_first_posted>
  <last_update_submitted>September 17, 2019</last_update_submitted>
  <last_update_submitted_qc>September 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</investigator_affiliation>
    <investigator_full_name>Gianluigi Giannelli</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

